Xtant Medical Holdings Inc. (XTNT) exhibits 62.9% gross margins and 12.8% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 3.7x enterprise multiple and 4.8% implied options volatility.
Sustained 62.9% gross profitability converts into 5.4% operating margin and 12.8% ROIC, outpacing sector cost of capital.
ROIC: 12.8% // GM: 62.9%YoY revenue trajectory of +14.2% paired with 24.95% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +14.2% // FCF YLD: 24.95%Altman Z-Score of 0.20 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 0.20 // F-SCORE: 9/9Trading at 24.0x trailing P/E (— Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: 3.7xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $0.29 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 0.0% net margins.
NET MARGIN: 0.0% // D/E: 0.22x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for XTNT & activate live FRED threshold breach alerts.